0001415889-21-004609.txt : 20210929
0001415889-21-004609.hdr.sgml : 20210929
20210929194304
ACCESSION NUMBER: 0001415889-21-004609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210927
FILED AS OF DATE: 20210929
DATE AS OF CHANGE: 20210929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brophy Michael Burkes
CENTRAL INDEX KEY: 0001697362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211293107
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-09292021_040948.xml
X0306
4
2021-09-27
0001604821
Natera, Inc.
NTRA
0001697362
Brophy Michael Burkes
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
false
true
false
false
CHIEF FINANCIAL OFFICER
Common Stock
2021-09-27
4
M
0
2292
A
110030
D
Common Stock
2021-09-27
4
S
0
2098
113.5576
D
107932
D
Common Stock
2021-09-27
4
S
0
8594
114.5099
D
99338
D
Common Stock
2021-09-27
4
S
0
13508
115.1758
D
85830
D
Common Stock
2021-09-27
4
S
0
800
116.1230
D
85030
D
Common Stock
2021-09-28
4
S
0
33
108.5490
D
84997
D
Common Stock
2021-09-28
4
S
0
914
109.7578
D
84083
D
Restricted Stock Unit
2021-09-27
4
M
0
2292
0
D
Common Stock
2292
22917
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.88 to $113.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.90 to $114.88 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.90 to $115.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.91 to $116.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
The RSUs vest over four years. 25% of the RSUs vested on March 27, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter.
/s/ Daniel Rabinowitz, Attorney-in-Fact
2021-09-29